OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation. [electronic resource]
Producer: 20051006Description: 835-43 p. digitalISSN:- 0934-0874
- Adult
- Antiviral Agents -- therapeutic use
- Cytomegalovirus -- genetics
- DNA, Viral -- antagonists & inhibitors
- Epstein-Barr Virus Infections
- Female
- Ganciclovir -- therapeutic use
- Gene Dosage
- Genome, Viral
- Hepatitis, Viral, Human -- virology
- Herpesvirus 4, Human -- genetics
- Humans
- Immunosuppressive Agents -- adverse effects
- Liver Transplantation -- adverse effects
- Lymphoma -- etiology
- Male
- Middle Aged
- Muromonab-CD3 -- adverse effects
- Postoperative Period
- Tacrolimus -- adverse effects
- Viral Load
- Viremia -- etiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.